IAAG
AVXL icon

Innovative Asset Advisors Group’s Anavex Life Sciences AVXL Stock Holding History

Innovative Asset Advisors Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.9K Sell
17,350
-3,750
-18% -$11.1K 0.02% 276
2026
Q1 		$64.8K Buy
+21,100
New +$91.4K 0.04% 270

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Innovative Asset Advisors Group's AVXL Position: Q2 2026 in Review

Innovative Asset Advisors Group reduced its Anavex Life Sciences (AVXL) stake by 18% in Q2 2026, selling an estimated $11.1K and leaving 17,350 shares worth $44.9K. The position accounts for 0.02% of the portfolio, ranked #276.

Innovative Asset Advisors Group first reported a position in AVXL in Q1 2026 and has held it in 2 quarters since. The position peaked at $64.8K in Q1 2026. 165 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Innovative Asset Advisors Group held 17,350 shares of Anavex Life Sciences worth $44.9K as of Q2 2026.
  • Innovative Asset Advisors Group sold 3,750 Anavex Life Sciences shares in Q2 2026, an estimated $11.1K.
  • Anavex Life Sciences made up 0.02% of Innovative Asset Advisors Group's portfolio in Q2 2026, its #276 holding.
  • Innovative Asset Advisors Group first reported a position in Anavex Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Innovative Asset Advisors Group's Anavex Life Sciences position peaked at $64.8K in Q1 2026.
  • 165 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Innovative Asset Advisors Group's 13F filing for Q2 2026, filed 5 Aug 2026.